J Neurol Surg A Cent Eur Neurosurg 2019; 80(02): 134-137
DOI: 10.1055/s-0038-1670636
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Lhermitte-Duclos Disease with Cervical Arteriovenous Fistula

Abdulaziz Oqalaa Almubarak
1   Division of Neurosurgery, Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
3   Neuroscience Department, Prince Mohammed Medical City, Jouf, Saudi Arabia
Anwar Ul Haq
1   Division of Neurosurgery, Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Ibrahim Alzahrani
1   Division of Neurosurgery, Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Essam Al Shail
1   Division of Neurosurgery, Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2   College of Medicine, Alfaisal University, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
› Institutsangaben
Weitere Informationen


28. Juni 2018

31. Juli 2018

05. Dezember 2018 (online)


Lhermitte-Duclos disease is a rare condition with less than 250 cases reported in the literature. It was considered a neoplastic or hamartomatous growth in the cerebellum. It commonly presents with symptoms of high intracranial pressure or obstructive hydrocephalus. Surgical resection is often curative. The lesion is associated with PTEN gene mutation, and it is considered to be one of the diagnostic criteria of Cowden's syndrome. Vascular tumors are reported in this syndrome, including glioblastomas and meningiomas. Furthermore, central nervous system vascular lesions were also reported in Lhermitte-Duclos disease, such as deep venous anomalies and brain arteriovenous fistulas. A report of an asymptomatic spinal cervical AVF in a patient with Lhermitte-Duclos disease was published in 2006. We present the second case of Lhermitte-Duclos disease associated with an asymptomatic spinal cervical AVF in a 17-year-old young woman with literature review of central nervous system vascular lesions in Lhermitte-Duclos disease.

  • References

  • 1 Lhermitte JDP. Sur un ganglioneurome diffus du cortex du cervelet. Bull Assoc Fr Etude Cancer 1920; 9: 99-107
  • 2 Okunaga T, Takahata H, Nakamura M, Iwasaki K. [A case report of Lhermitte-Duclos disease with systematic AVMs]. No To Shinkei 2003; 55 (03) 251-255
  • 3 Vantomme N, Van Calenbergh F, Goffin J, Sciot R, Demaerel P, Plets C. Lhermitte-Duclos disease is a clinical manifestation of Cowden's syndrome. Surg Neurol 2001; 56 (03) 201-204 ; discussion 204–205
  • 4 Turnbull MM, Humeniuk V, Stein B, Suthers GK. Arteriovenous malformations in Cowden syndrome. J Med Genet 2005; 42 (08) e50-e50
  • 5 Tan W-H, Baris HN, Burrows PE. , et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 2007; 44 (09) 594-602
  • 6 Lok C, Viseux V, Avril MF. , et al; Cancerology Group of the French Society of Dermatology. Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore) 2005; 84 (02) 129-136
  • 7 Akiyama Y, Ikeda J, Ibayashi Y, Nonaka T, Asai Y, Houkin K. Lhermitte-Duclos disease with cervical paraspinal arteriovenous fistula. Neurol Med Chir (Tokyo) 2006; 46 (09) 446-449
  • 8 Kalia SS, Adelman K, Bale SJ. , et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017; 19 (02) 249-255
  • 9 Ambler M, Pogacar S, Sidman R. Lhermitte-Duclos disease (granule cell hypertrophy of the cerebellum) pathological analysis of the first familial cases. J Neuropathol Exp Neurol 1969; 28 (04) 622-647
  • 10 Oppenheimer DR. A benign tumour of the cerebellum; report on two cases of diffuse hypertrophy of the cerebellar cortex with a review of nine previously reported cases. J Neurol Neurosurg Psychiatry 1955; 18 (03) 199-213
  • 11 Reeder RF, Saunders RL, Roberts DW, Fratkin JD, Cromwell LD. Magnetic resonance imaging in the diagnosis and treatment of Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Neurosurgery 1988; 23 (02) 240-245
  • 12 Vinchon M, Blond S, Lejeune JP. , et al. Association of Lhermitte-Duclos and Cowden disease: report of a new case and review of the literature. J Neurol Neurosurg Psychiatry 1994; 57 (06) 699-704
  • 13 Buhl R, Barth H, Hugo HH, Straube T, Mehdorn HM. Dysplastic gangliocytoma of the cerebellum: rare differential diagnosis in space occupying lesions of the posterior fossa. Acta Neurochir (Wien) 2003; 145 (06) 509-512 ; discussion 512
  • 14 Eng C, Murday V, Seal S. , et al. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?. J Med Genet 1994; 31 (06) 458-461
  • 15 Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC. Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 1991; 29 (05) 517-523
  • 16 Beroš V, Sajko T, Talan-Hranilovic J, Negovetić L. Intracranial hypertension due to Lhermitte Duclos disease: case report. Acta Clin Croat 2000; 39: 181-186
  • 17 Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000; 37 (11) 828-830
  • 18 Milligan BD, Giannini C, Link MJ. Ganglioglioma in the cerebellopontine angle in a child. Case report and review of the literature. J Neurosurg 2007; 107 (4, Suppl): 292-296
  • 19 Zentner J, Wolf HK, Ostertun B. , et al. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry 1994; 57 (12) 1497-1502
  • 20 Nowak DA, Trost HA. Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm?. Acta Neurol Scand 2002; 105 (03) 137-145
  • 21 Kulkantrakorn K, Awwad EE, Levy B. , et al. MRI in Lhermitte-Duclos disease. Neurology 1997; 48 (03) 725-731
  • 22 Klisch J, Juengling F, Spreer J. , et al. Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 2001; 22 (05) 824-830
  • 23 Awwad EE, Levy E, Martin DS, Merenda GO. Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement. AJNR Am J Neuroradiol 1995; 16 (08) 1719-1720
  • 24 Nair P, Pal L, Jaiswal AK, Behari S. Lhermitte-Duclos disease associated with dysembryoplastic neuroepithelial tumor differentiation with characteristic magnetic resonance appearance of “tiger striping.”. World Neurosurg 2011; 75 (5-6): 699-703
  • 25 Hariri OR, Khachekian A, Muilli D. , et al. Acute-onset cerebellar symptoms in Lhermitte-Duclos disease: case report. Cerebellum 2013; 12 (01) 127-130
  • 26 Nowak DA, Trost HA, Porr A, Stölzle A, Lumenta CB. Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 2001; 103 (02) 105-110
  • 27 Zhou XP, Marsh DJ, Morrison CD. , et al. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 2003; 73 (05) 1191-1198
  • 28 Déléris P, Bacqueville D, Gayral S. , et al. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 2003; 278 (40) 38884-38891
  • 29 Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 2002; 21 (03) 469-475
  • 30 Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22 (14) 2954-2963